ã¡ãã£ã¢èšäº
ããããã¯ã¹è£œã¯ã¯ãã³äŸçµŠå¥çŽã1å5åäžååã22幎ãã
ããºãææ°ããŒã¯ 2,573
twitterã³ã¡ã³ã 505ä»¶äž 101ïœ200件
茞å
¥ãããªããŠåœç£ã ãã
ããŒã¹ã¿ãŒæ¥çš®ã®æºåã¯äžå
šã§ããªð©
æã¡ãã人ã ãæã£ãŠãð
æã¡ãã人ã ãæã£ãŠãð
æ¥æ¬æ¿åºãåªç§ã§è¯ãã£ããã
æå ±ã§ããmRNAã«æµæãããã®ãªãããããã¯ã¹ã§ãã¢ã¹ãã©ãŒãã«ã§ã¯ã©ãã§ãããïŒ
åèè³æ
ããããã¯ã¹ã®å®å šæ§ãšå¹æ
(2021.6.30 New England Journal of Medicine)
âã«resultã®åèš³
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
ããããã¯ã¹ã®å®å šæ§ãšå¹æ
(2021.6.30 New England Journal of Medicine)
âã«resultã®åèš³
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
æ°ããªã¯ã¯ãã³
ããã«æåŸ
ããã
ãå瀟ãªã©ã§ã¯çŸåšãè¿œå æ¥çš®ãžã®äœ¿çšãèŠéã«éçºãé²ããŠãããå€ç°æ ªãžã®å¯Ÿå¿ãæ³å®ã
ããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã®äžéšã䜿ãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ãšåŒã°ããçš®é¡ã§ããããŸã§ã«ãBåèçã®ã¯ã¯ãã³ãªã©ã§çšããããŠããã
ããŒã¹ã¿çšãªã®ããªïŒ
ããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã®äžéšã䜿ãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ãšåŒã°ããçš®é¡ã§ããããŸã§ã«ãBåèçã®ã¯ã¯ãã³ãªã©ã§çšããããŠããã
ããŒã¹ã¿çšãªã®ããªïŒ
æ¥å¹ŽåºŠã®ã¯ã¯ãã³ç¢ºå®ïŒ
ã³ããã«ã¯ã¯ã¯ãã³ã決ãæã
ãã®ã¯ã¯ãã³ãåœæ°ã®çºã«æ²¢å±±ç¢ºä¿ããŠãããè æ¿æš©ã«ã¯æè¬ãããªãã
ãã®ã¯ã¯ãã³ãåœæ°ã®çºã«æ²¢å±±ç¢ºä¿ããŠãããè æ¿æš©ã«ã¯æè¬ãããªãã
æ¥å¹Žä»¥éãã¯ã¯ãã³éšåã¯ç¶ãããã§ãã
æ©ãããŒã¹ããããŠããâ
ã¯ã¯ãã³2åæ¥çš®åã¯ç¢ºä¿ã§ããŠãã¿ãããªã®ã§ã3åç®çšïŒå®æçã«æããªããšå¹æãä¿ãŠãªããã§ããããã
ããããæ¬åœã«åœãæãæ¿çã ãã
æ¿èª¿äŒé·ããã¯ã¯ãã³æ¥çš®ããŠæ°æéã§çµ¶åœãã人ããããšãããã¿ã©ã¡ããã€ãæè¿ãçºä¿¡ããŠãç«æ²æ°äž»å ã«ã¯äžå¯èœã ãã
æ¿èª¿äŒé·ããã¯ã¯ãã³æ¥çš®ããŠæ°æéã§çµ¶åœãã人ããããšãããã¿ã©ã¡ããã€ãæè¿ãçºä¿¡ããŠãç«æ²æ°äž»å ã«ã¯äžå¯èœã ãã
> ç±³ããããã¯ã¹è£œã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå
ã§çç£ãæµéãæ
ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµ
åŸ æã®ãã¥ãŒã¹ãªãã ãã©ãADEã®æžå¿µããªã
ããšãŸãæŠç°ïŒ
ã¢ãã«ãã®ä»¶ã§ã€ãã€ãå°è±¡ãâŠ
åŸ æã®ãã¥ãŒã¹ãªãã ãã©ãADEã®æžå¿µããªã
ããšãŸãæŠç°ïŒ
ã¢ãã«ãã®ä»¶ã§ã€ãã€ãå°è±¡ãâŠ
æ¥å¹Žãè¶çªã¯ç¶ãâŠèªåã§å€æããŠãããã§ãæã¡ãã人ã¯ã©ãã©ãæã£ãŠæ§ããªããã©ãæã¡ãããªãæã
ãå·»ã蟌ãŸãªãã§ããâŠ
现èæ§å
ç«ãåŸãããmRNAã¯ã¯ãã³ããå¹æã匱ãããšæã£ãã90%è¿ãçºçäºé²å¹æãããŒ
3åç®çšããªãã
ãŸãã¢ãã«ãã¯2åç®å¯äœçšãšã°ãã£ããã§åé¿ã§ãããªãâŠ
3åç®çšããªãã
ãŸãã¢ãã«ãã¯2åç®å¯äœçšãšã°ãã£ããã§åé¿ã§ãããªãâŠ
幎å
ã«ã¢ãã«ãæã€äºå®ã ãã©ã3åç®ã«ããããããã¯ã¹ãæãŠã°ããã®ããªã
ãããªãã«å®çšåããã®å®çžŸã®ããäœçšæ©åºçãåšç¥ãããŠããã¯ã¯ãã³ãªãã°æã€ãããšãã人ãå¢ãããšæãã®ã§éžæè¢ãå¢ããã®ã¯è¯ãäºã
ããããã¯ã¹è£œã¯ã¯ãã³ã®æ¿èªã©ããªããããªãŒãã¢ã¡ãªã«ãšãæ¥ãã§æ¿èªããã¡ãªãããªãããã ãã©ãã©ããå
é£ãåããã
ðððð
ããã俺ãã俺ãïŒ
ã ã£ãŠãäžèº«ã¯äœã§ãè¯ããã ãïŒ
ã©ãã調ã¹ããããã
ãšãã倢ãèŠãã®ããã
ã ã£ãŠãäžèº«ã¯äœã§ãè¯ããã ãïŒ
ã©ãã調ã¹ããããã
ãšãã倢ãèŠãã®ããã
åœå
çç£ã§ããã€Båèçã¯ã¯ãã³ãšåã¿ã€ããšããããšããçŸåšã®mRNAã¯ã¯ãã³ãæ¬é ããŠã人éã«ãåºããããããããããªããããŒã¹ã¿ãŒæ¥çš®ãå¯èœãªãç§ãæã£ãŠã¿ããã
ã¯ã¯ãã³ãªããŠå¹ããªãã®ãã»ã»ã»
ãããããŠããã»ã»ã»ã»
ãããããŠããã»ã»ã»ã»
äŒæ¥åã ãèŠããšããã«ãã£ã¹ç³»åããšæã£ããéããããª
åœç£ã§çç£ãåºæ¥ãŠãªã以äžãæ©ãã®ç¢ºä¿ã¯éèŠããéããããã®ã¯åœç¶ããããªãã§æžãæ¹æ³ãããã°ã©ãããã£ãŠããšæããæ ¹æ§ã§æ²»ãã¿ãããªèãã¯ãããŠãã
ãã3åç®ã©ãããæ¯å¹Žã¯ã¯æã€æ°æºã
ãããªãã§ããããã£ã±ãæããªãã®ãæ£è§£ãããªããæã¡ãããªã£ããäœæã§ãæãŠããã§ããâãããšããããããã¯ã¯ã¯æã€ã®ã«ãã¯ã¯ãã¹ãå¿
èŠã«ãªãã®ããªâãäžåãã¯ã¯æã£ãŠãªã奎ã«ã¯æã€ãªâãã£ãŠå»ã¯ã©ãèšãããð
çµãããèŠããªãäžã§ãé·ææŠã®æºåã¯é²ãã§ããããã --
ååŽçã²ã©ãé§ã蟌ã¿å¥çŽ
é§
åçåŠNOVAã¿ããã«é§
åæ¥çš®NOVAã¿ãããªæãã§æ°è»œã«åããããããã«ãªãã°ãããªð
ã®ã°ã°ã°ã
é§
åã«æ¥çš®äŒå Žã€ãããªããšã
é§ åçåŠã¿ããã«ã
é§ åçåŠã¿ããã«ã
å
ç å匷äžè¶³ã§ãã¿ãŸãããã¿ã³ãã¯çµã¿æãã¯ã¯ãã³ã¯ã©ããªãã§ããïŒ mrna,ãŠã€ã«ã¹ãã¯ã¿ãŒãããŸãšãã§ããïŒ
æ°ããçš®é¡ãå¢ããïŒïŒ
ããŒãŒãŒïŒãããã£ãŠã°ð±
ã¹ãŽã€ç¢ºä¿ã ãªâŠ
次ã¯ãããã¯ã¹ãããã¡ãªã¿ã«äžåœè£œã®ã»ãã¯ã·ãããã¯ã¹ãšãã£ãŠãŸãå¥ç©ãçŽããããååã
ããã¯ãããã¥ãŒã¹
åãªãåžå Žã«ãªã£ãŠãŸããã
ãããŠæãããã®ã¯å®¶çã§ããããã
ãããŠæãããã®ã¯å®¶çã§ããããã
ãŸããã€ããã®ãšå¥çŽããã®ãã
ð
ð
çš®é¡ãå¢ããŠããæ¥çš®ããã¯ã¯ãã³ããåæãšãç°¡åã«åºæ¥ããšã¯æããªãããå¢ããããŠåŸã
管çã倧å€ã«ãªããªãã®ããªãèªåã®æ¥çš®ããŠãã¯ã¯ãã³ãäŸçµŠç¡ããªããšãããªã¹ã¯åæ£ã«ã¯ãªããã ãããã©ã
â
â
ïœïŒ²ïŒ®ïŒ¡ã¯ã¯ãã³ãé¿ããŠã人ã«çµã¿æãã¿ã³ãã¯ã¯ã¯ãã³ã®éèŠã¯ããããã
ã·ãããã¯ãããªããªããªãã±ãŒð
ããã¢ãã«ãã®å¯åå¿ãã€ãããŠã€ã€ãªã®ã§ããã·ãªã3åç®ã¯ããããã
ãããããªçš®é¡ã®ã¯ã¯ãã³ã䜿ããããã«ãªãã®ã¯è¯ãã
ãããªãäžç¢ºå®ãªåå¿ãå°ãªãã
å®å šæ§ãé«ãã®ããªïŒïŒ
ã·ãããã¯ã¹ãšäžæåéãã ãã©ã
å 容ãå šç¶éãwww
å®å šæ§ãé«ãã®ããªïŒïŒ
ã·ãããã¯ã¹ãšäžæåéãã ãã©ã
å 容ãå šç¶éãwww
ã·ãªãã®ã¯åºãŠãããªãããã«ãªã£ãŠããããã
ãããŠæ¥æ¥ãããã«ã€ãã«ã¡ã¯ãã³ãšã»ãŒåæåã®è¬ããã¡ãã®åœã®äŒç€ŸããåºãŠãããã³ããæ²»çè¬ãšããŠäœ¿ãããã§ãããã
ãããŠæ¥æ¥ãããã«ã€ãã«ã¡ã¯ãã³ãšã»ãŒåæåã®è¬ããã¡ãã®åœã®äŒç€ŸããåºãŠãããã³ããæ²»çè¬ãšããŠäœ¿ãããã§ãããã
ãã£ïŒæ©ãããŠãããŒ
ã¯ã¯ãã³ãã¹ããŒããšãèšãåºããŠããŠ
ç掻ãã«ãããªã£ãŠããŠããã ã
ã¯ã¯ãã³ãã¹ããŒããšãèšãåºããŠããŠ
ç掻ãã«ãããªã£ãŠããŠããã ã
ãŸãæŠç°ãªãã ãã
3åç®ã¯ããããã¯ã¹ã§ãããããã
å¹æçãªã¯ã¯ãã³ãå®æãããã®ã«ãäŒæ¥äŸ¡å€ãã¢ãã«ãã®1/10çšåºŠãããªãã
3åç®ã¯ããããã¯ã¹ã§ãããããã
å¹æçãªã¯ã¯ãã³ãå®æãããã®ã«ãäŒæ¥äŸ¡å€ãã¢ãã«ãã®1/10çšåºŠãããªãã
ããããã¯ã¹è£œã¯ã¯ãã³äŸçµŠå¥çŽ
ïŒâç±³ããããã¯ã¹è£œã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå ã§çç£ãæµéãæ ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµãããšçºè¡šâ
â
岞ç°ãªãææ察ç匷åã«ã·ãããã¯éžã³ãã
ïŒâç±³ããããã¯ã¹è£œã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«ã€ããŠãæ©ããã°2022幎åé ãã1å5åäžååã®äŸçµŠãåããå¥çŽããåœå ã§çç£ãæµéãæ ãæŠç°è¬åå·¥æ¥ãšã®éã§ç· çµãããšçºè¡šâ
â
岞ç°ãªãææ察ç匷åã«ã·ãããã¯éžã³ãã
çµã¿æãã¿ã³ãã¯åã¯ããããããã©ã22幎ã ã£ããå¡©é矩ã®æ¹ã«æåŸ
ããããšããã§ã¯ãã
ã€ãŸãïŒåç®ã¯ããã©ãš..._ã(ïŸâœïŸ*)
ãŸããžããªã®åºã§ããã
次ãã次ãžãš
次ãã次ãžãš
äžç¬ã·ãããã¯ããšæã£ãŠããŸã£ãð£ ããã¯æ¢ããŠââ
ããã§çŸæç¹ã§åã¯ã¯ãã³ã®æ¹ã
ãå®å¿ããŠæ¥çš®ã§ããŸããã
ã泚å°ãæã¡ããæ¹ãæãããè² ããªãæ¹ã¯ã
åºæ¥ãã°åºæ¥ãã°ãã¡ãã®æ¹ãä»ãæãããŠãã¢ããã確å®ã«å®å šæ§ã確èªãããŠãŸãã®ã§âŠæ¥å¹Žæ©ã ã§ããã
å®ãããšâŠð€
å Žæ: Asagayaminami
åºæ¥ãã°åºæ¥ãã°ãã¡ãã®æ¹ãä»ãæãããŠãã¢ããã確å®ã«å®å šæ§ã確èªãããŠãŸãã®ã§âŠæ¥å¹Žæ©ã ã§ããã
å®ãããšâŠð€
å Žæ: Asagayaminami
mRNAãããªãããã§ãã
ïŒæ¬ç®ïŒæ¬ç®ãæã€äººã¯å€§å€ã ãšæããŸãããé 匵ã£ãŠäžããã
ã³ããã¯ã¯ãã³ã倫婊æã£ãŠäžçªæçã§æã£ãã®ã ããã©
12æ³ã®æãåã«ã¯å°ãèºèºããŠããŸã£ãŠâŠæ§åèŠããŠãŸã
ã§ããããªã1æã£ãŠãè¯ãããª
12æ³ã®æãåã«ã¯å°ãèºèºããŠããŸã£ãŠâŠæ§åèŠããŠãŸã
ã§ããããªã1æã£ãŠãè¯ãããª
æµéã¯ãããã¥ãŒã¹ã ãã©ãããæŠç°è¬åã«ã¯ãããããªãã¢ãã«ãã§ãç°ç©æ··å
¥ã®ä»¶ã§æ£åŒãªè¬çœªãããªãæªåŸ³äŒæ¥ã«
ããåœæ°ã¯æ ã¡ããã§ãè
¹ãã£ã±ãã
ã©ãããªããããããã®ãèŒžå ¥ããŠé ã£ãŠããã
ã©ãããªããããããã®ãèŒžå ¥ããŠé ã£ãŠããã
鬌æ»
ã®åãã«ãã²ãšãããã (æ¡æ£åžæ)
ð²ã©ãã¶ã€ã®æ£®ïŒð
ð²ã©ãã¶ã€ã®æ£®ïŒð
ã¡ãã£ãšååã®äŒŒãŠãäžè¯è£œã¯ã¯ãã³ã®ã·ãããã¯ã£ãŠããã®ããã£ãŠã ãª
åæé®®ã§ãããããããšæåŠãã代ç©ã£ãŠãããªããªãã€ãããã€
åæé®®ã§ãããããããšæåŠãã代ç©ã£ãŠãããªããªãã€ãããã€
æŠç°è¬åå·¥æ¥ãæè¡ç§»è»¢ãåããŠåœå
ã§çç£ããäºå®
ã¡ãã»ã³ãžã£ãŒRNAã§ã¯ãªãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³
ã¡ãã»ã³ãžã£ãŒRNAã§ã¯ãªãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³
åŸ
ã£ãŠãŸãã
ããã¯çµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ã
ä»åœã®æ害äºè±¡çµæãå
ã¿é ããå
¬éããããã«é¡ãããã
çŸè¡ã®ã¯ã¯ãã³æ¥çš®ããããã«ã¿ã³ããã«ã¯ææããŠããŸãã£ãŠä»åœã§èšŒæãããŠãã®ã«
ãŸãããçšéã®ç¡é§é£ãïŒ
ãã£ã±ããã¢ãã¯ãœè ããã ãªïŒ
ãŸãããçšéã®ç¡é§é£ãïŒ
ãã£ã±ããã¢ãã¯ãœè ããã ãªïŒ
ååèŠééããŠããã£ããã·ãããã¯ãšããããã¯ã¹ã¯éãäŒç€Ÿãªãã ãªã
æ®éã«ã¬ãŒã¹ãŒãšæ²³éã¡ããåããªãã£ãã
ã¢ã¹ãã©ãå«ãããæãäœããããã¯ã¯ãã³ããããã
ã¢ã¹ãã©ãå«ãããæãäœããããã¯ã¯ãã³ããããã
è¯ããã¥ãŒã¹ããããŠãã¡ã€ã¶ãŒã¿ããã«2ã¶æååãã«ãªããªãïŒæ©ãæã¡ããã§ãã
3åç®ã®ããŒã¹ã¿ãŒïŒð€
äžåœã®ã·ãããã¯ããšæã£ãããã¢ã¡ãªã«ã®ããããã¯ã¹ãã
ãçµã¿æãããã±ãã¯ã¯ãã³ãã1å5åäžååã ã£ãŠ
ãçµã¿æãããã±ãã¯ã¯ãã³ãã1å5åäžååã ã£ãŠ
ãŸãåœå
æ²»éšããããŠãªãæµ·å€ã¯ã¯ãã³ã®å¥çŽãïœ
æŠç°ããååŽçãžããã¯ããã¯ãåãã®ãïŒ
ã¯ã¯ãã³å幎ããå¹ããã
äœãã¹ãã€ã¯èçœã®æ¯ã«ããããã¡ãªããã¯çã
æŠç°ããååŽçãžããã¯ããã¯ãåãã®ãïŒ
ã¯ã¯ãã³å幎ããå¹ããã
äœãã¹ãã€ã¯èçœã®æ¯ã«ããããã¡ãªããã¯çã
ã¯ïŒ
ãŸã æã€ã®ïŒ
åœæ°ã®å å²ãäºåæãŠã°éå£å ç«ãšãã話ã¯ã©ããªã£ãã®ïŒ
æã¡ããããšæ®ºè«å€ãæçç©è³ªãšåãã§å¹ããªããªããèæ§ãŠã€ã«ã¹ãåºãŠããåæ¯ãåºããã ãã ãšåãããªãã®ãïŒ
ãŸã æã€ã®ïŒ
åœæ°ã®å å²ãäºåæãŠã°éå£å ç«ãšãã話ã¯ã©ããªã£ãã®ïŒ
æã¡ããããšæ®ºè«å€ãæçç©è³ªãšåãã§å¹ããªããªããèæ§ãŠã€ã«ã¹ãåºãŠããåæ¯ãåºããã ãã ãšåãããªãã®ãïŒ
ãã£ãïŒ
ãæ©ããã°2022幎åé ããã
ãã£ãšæ©ããªããããªïŒ
ããããšãããããŸãã
ãæ©ããã°2022幎åé ããã
ãã£ãšæ©ããªããããªïŒ
ããããšãããããŸãã
ãã¡ã€ã¶ãŒïŒã¢ãã«ãïŒããããã¯ã¹ïŒ
ãããŒã¹ã¿ãŒã·ã§ããã
ïŒå€èº«é³å£°ïŒæŽŸæãªãšãã§ã¯ãïŒå€èº«å®äº
ãããŒã¹ã¿ãŒã·ã§ããã
ïŒå€èº«é³å£°ïŒæŽŸæãªãšãã§ã¯ãïŒå€èº«å®äº
ã·ãããã¯ãªãè
è¿œå æ¥çš®ãžã®äœ¿çšãèŠéã«éçºãé²ããŠãããå€ç°æ ªãžã®å¯Ÿå¿ãæ³å®ããŠããã
ããããã¯ã¹è£œã¯ããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã®äžéšã䜿ãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ãšåŒã°ããçš®é¡
ããããã¯ã¹è£œã¯ããŠã€ã«ã¹ã®ã¿ã³ãã¯è³ªã®äžéšã䜿ãçµã¿æ¿ãã¿ã³ãã¯ã¯ã¯ãã³ãšåŒã°ããçš®é¡
ã³ããã¯ã¯ãã³ã¯åœæ°ãã¡ãå幎ã«äžåºŠæã€ããã«å¥çŽãããŠãã§ããã
ã€ãŸããããæå¹æéãªã®ã§ãã
ã€ãŸããããæå¹æéãªã®ã§ãã
ãããæ°ãŒã
æã¡ãã人ã¯ã©ããïœð±
æã¡ãã人ã¯ã©ããïœð±
çµã¿æãã¿ã³ãã¯è³ªãªãå¯åå¿ãmRNAããå°ãªããã ãããã ãã®åçã®Båèçã®ã¯ã¯ãã³ã¯4åç®ã®è¿œå æ¥çš®ã§ããããéœæ§ã ã£ããããå
ç«ã®ä»ãã«ããç¹ç°äœè³ªã®äººã¯æäœæ€æ»ããã»ãããããšã¯æããã©ããããŸã§ã®ãã³ãã¯ãŒã¯ããã®ããªã
æ¥å¹Žãã©ããªããããããªããã©ãããããã
å€äººã«æ¯ã¹ãŠæ¥æ¬äººã¯ãŠã€ã«ã¹ã«åŒ·ããããæ¯å¹ŽïŒåäœã®ãã·ã¢ã³ã«ãŒã¬ããã§æžã¿ããã§ããð
ãããŒã ããæã¡ãŸãïŒ
æ¥çš®åŸãå¯åå¿ã§çºç±ããªããªãããã¡ããããŒã¹ã¿ãŒæ¥çš®ããããä»çš®ã§ãå¯èœãªããïœ
æ¥å¹Žãã¬ã³ã¬ã³çæ²æã€ã€ãããïŒ
ãªãã§çŽè¿ã§ç°ç©æ··å
¥æ€æ»ã¹ã«ãŒããæŠç°è£œè¬ã«ä»»ãããã ããåãç°ç©æ··å
¥ãããããå°æåæã¯æ¥ååæ¢åŠåãªã®ã«ã
â»ã¡ãããã·ãããã¯ã¯äžèŠã§ãâºïž
ïŒæ©ããã°2022幎åé ããâŠ
ããã¯ãã¡ã€ã¶ãŒãã¢ãã«ãªãšã®äº€å·®æ¥çš®ãšããããšã«ãªãã®ã ãããïŒâŒ
ãããçµã¿æãã¿ã³ãã¯ã¯ã¯ãã³ã
åŸ
ã£ãŠãããæ©ãããŠïŒäºçŽåãããããïŒ
çŸåšã䜿çšäžã®ã¯ã¯ãæ§ã
ãªå¯åå¿ãæ»äº¡è
ããæããã«ãªãã€ã€ããã®ã§ãæ°è¬ãžåãæ¿ãã§ãããããçµæã¯ãåãã§ãããããã©ã...
æ¥æ¬ã£ãŠå€äº€ããããããããªç¢ºä¿ã§ãããã®ãªã®ïŒ
ãå
æãæã£ãŠç¢ºä¿ããŠããããšã¯å€§äºã亀差æ¥çš®ãããŒã¹ã¿ãŒã·ã§ããã§ã䜿ãããããããŠãããŠæã¯ãªããããã¯æ£åœã«æ¿åºãè©äŸ¡ããã¹ãã§äœã§ãå察æ¿å
ã§ã¯ãŸã£ããé²æ©ããªãã
ãã¡ã€ã¶ãŒãã¢ãã«ããã¢ã¹ãã©ãŒãã«3å€ã®ã¯ã¯ãã³ã®ææäºé²å¹æãæ¯èŒããããŒã¿ãååã«ç¡ãã®ã«ããã«4å€ç®ã®ã¯ã¯ãã³ãæ¿èªãããïŒã£ãŠè©±ð€
åœå®¶èŠæš¡ã®äººäœå®éšããã
ãã®åœã®è¡æ¿ã¯è¡è¿·ã£ãŠãð
åœå®¶èŠæš¡ã®äººäœå®éšããã
ãã®åœã®è¡æ¿ã¯è¡è¿·ã£ãŠãð
ããŒã¹ã¿ãŒ(3åç®)çšããªïŒ
2022幎åé ãšããã
2022幎åé ãšããã
åãã¿ã³ãã¯è³ªã¯ã¯ãã³ã®å¡©é矩ã¯æ²»éšããçŽãã§æéã«éã«åããªãã£ãããâ
mRNAã¯ãŸã ãŸã åãããªãããšã ãããªã®ã§ãæ¢ããŠãããŸãã